Peter L. Hoang has been appointed president and chief executive officer, TapImmune, Inc. Dr. Glynn Wilson, who was recently re-appointed as chairman, will now serve in a new role as the company’s Strategic Advisor.   Mr. Hoang has more than 20 years of investment banking, venture capital, immuno-oncology and public company executive management experience. Most recently he served as senior vice president of business development and Strategy at Bellicum Pharmaceuticals. He also served as m...